Cargando…

Cardiovascular Risks in Prediabetes: Preliminary Data on “Vasculopathy Triad”

BACKGROUND: Subclinical cardiovascular disease is inherent in complications of diabetes mellitus. It occurs before the obvert manifestation of cardiovascular disease complication in diabetes, and involves vasculopathy triad or three major vascular events comprising stasis, endothelial dysfunction, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nwose, Ezekiel U, Richards, Ross S, Bwititi, Phillip T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114010/
https://www.ncbi.nlm.nih.gov/pubmed/25077081
http://dx.doi.org/10.4103/1947-2714.136913
_version_ 1782328381153476608
author Nwose, Ezekiel U
Richards, Ross S
Bwititi, Phillip T
author_facet Nwose, Ezekiel U
Richards, Ross S
Bwititi, Phillip T
author_sort Nwose, Ezekiel U
collection PubMed
description BACKGROUND: Subclinical cardiovascular disease is inherent in complications of diabetes mellitus. It occurs before the obvert manifestation of cardiovascular disease complication in diabetes, and involves vasculopathy triad or three major vascular events comprising stasis, endothelial dysfunction, and atherothrombosis. AIM: This study was to examine evidence of vasculopathy triad in prediabetes, biomarkers of stasis, endothelial dysfunction, and atherothrombosis in prediabetes were compared with apparently healthy group. MATERIALS AND METHODS: Eighty-one participants with results for plasma D-dimer, homocysteine, and whole blood viscosity were selected from a research database. The participants consisted of control (n = 44) and prediabetes (n = 37) based on clinical history and laboratory results. RESULTS: Multivariate analysis shows a significantly higher level of vasculopathy in prediabetes than in the control group (P > 0.0001). Blood viscosity (P < 0.04) and homocysteine (P < 0.03) are significantly higher in prediabetes than in controls. Average levels for plasma D-dimer are also higher in prediabetes than in control, but not statistically significant in this particular analysis. CONCLUSION: This study suggests a novel application of known idea, vasculopathy triad that could be used for assessment of subclinical cardiovascular disease in prediabetes.
format Online
Article
Text
id pubmed-4114010
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-41140102014-07-30 Cardiovascular Risks in Prediabetes: Preliminary Data on “Vasculopathy Triad” Nwose, Ezekiel U Richards, Ross S Bwititi, Phillip T N Am J Med Sci Original Article BACKGROUND: Subclinical cardiovascular disease is inherent in complications of diabetes mellitus. It occurs before the obvert manifestation of cardiovascular disease complication in diabetes, and involves vasculopathy triad or three major vascular events comprising stasis, endothelial dysfunction, and atherothrombosis. AIM: This study was to examine evidence of vasculopathy triad in prediabetes, biomarkers of stasis, endothelial dysfunction, and atherothrombosis in prediabetes were compared with apparently healthy group. MATERIALS AND METHODS: Eighty-one participants with results for plasma D-dimer, homocysteine, and whole blood viscosity were selected from a research database. The participants consisted of control (n = 44) and prediabetes (n = 37) based on clinical history and laboratory results. RESULTS: Multivariate analysis shows a significantly higher level of vasculopathy in prediabetes than in the control group (P > 0.0001). Blood viscosity (P < 0.04) and homocysteine (P < 0.03) are significantly higher in prediabetes than in controls. Average levels for plasma D-dimer are also higher in prediabetes than in control, but not statistically significant in this particular analysis. CONCLUSION: This study suggests a novel application of known idea, vasculopathy triad that could be used for assessment of subclinical cardiovascular disease in prediabetes. Medknow Publications & Media Pvt Ltd 2014-07 /pmc/articles/PMC4114010/ /pubmed/25077081 http://dx.doi.org/10.4103/1947-2714.136913 Text en Copyright: © North American Journal of Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Nwose, Ezekiel U
Richards, Ross S
Bwititi, Phillip T
Cardiovascular Risks in Prediabetes: Preliminary Data on “Vasculopathy Triad”
title Cardiovascular Risks in Prediabetes: Preliminary Data on “Vasculopathy Triad”
title_full Cardiovascular Risks in Prediabetes: Preliminary Data on “Vasculopathy Triad”
title_fullStr Cardiovascular Risks in Prediabetes: Preliminary Data on “Vasculopathy Triad”
title_full_unstemmed Cardiovascular Risks in Prediabetes: Preliminary Data on “Vasculopathy Triad”
title_short Cardiovascular Risks in Prediabetes: Preliminary Data on “Vasculopathy Triad”
title_sort cardiovascular risks in prediabetes: preliminary data on “vasculopathy triad”
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114010/
https://www.ncbi.nlm.nih.gov/pubmed/25077081
http://dx.doi.org/10.4103/1947-2714.136913
work_keys_str_mv AT nwoseezekielu cardiovascularrisksinprediabetespreliminarydataonvasculopathytriad
AT richardsrosss cardiovascularrisksinprediabetespreliminarydataonvasculopathytriad
AT bwititiphillipt cardiovascularrisksinprediabetespreliminarydataonvasculopathytriad